1. Home
  2. NVCR vs TDC Comparison

NVCR vs TDC Comparison

Compare NVCR & TDC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NVCR
  • TDC
  • Stock Information
  • Founded
  • NVCR 2000
  • TDC 1979
  • Country
  • NVCR Switzerland
  • TDC United States
  • Employees
  • NVCR N/A
  • TDC N/A
  • Industry
  • NVCR Medical/Dental Instruments
  • TDC Computer Software: Prepackaged Software
  • Sector
  • NVCR Health Care
  • TDC Technology
  • Exchange
  • NVCR Nasdaq
  • TDC Nasdaq
  • Market Cap
  • NVCR 1.9B
  • TDC 2.3B
  • IPO Year
  • NVCR 2015
  • TDC 2007
  • Fundamental
  • Price
  • NVCR $15.58
  • TDC $20.35
  • Analyst Decision
  • NVCR Buy
  • TDC Hold
  • Analyst Count
  • NVCR 6
  • TDC 10
  • Target Price
  • NVCR $34.17
  • TDC $31.56
  • AVG Volume (30 Days)
  • NVCR 736.7K
  • TDC 2.2M
  • Earning Date
  • NVCR 04-24-2025
  • TDC 05-05-2025
  • Dividend Yield
  • NVCR N/A
  • TDC N/A
  • EPS Growth
  • NVCR N/A
  • TDC 90.16
  • EPS
  • NVCR N/A
  • TDC 1.16
  • Revenue
  • NVCR $605,220,000.00
  • TDC $1,750,000,000.00
  • Revenue This Year
  • NVCR $3.14
  • TDC N/A
  • Revenue Next Year
  • NVCR $10.63
  • TDC $0.55
  • P/E Ratio
  • NVCR N/A
  • TDC $17.54
  • Revenue Growth
  • NVCR 18.82
  • TDC N/A
  • 52 Week Low
  • NVCR $11.70
  • TDC $18.43
  • 52 Week High
  • NVCR $34.13
  • TDC $38.45
  • Technical
  • Relative Strength Index (RSI)
  • NVCR 34.24
  • TDC 38.13
  • Support Level
  • NVCR $15.49
  • TDC $20.00
  • Resistance Level
  • NVCR $17.06
  • TDC $20.98
  • Average True Range (ATR)
  • NVCR 1.06
  • TDC 0.97
  • MACD
  • NVCR -0.01
  • TDC 0.03
  • Stochastic Oscillator
  • NVCR 20.42
  • TDC 40.34

About NVCR NovoCure Limited

NovoCure Ltd serves in the healthcare sector of the United States. Its business involves the development, manufacture and commercialization of Tumor Treating Fields (TTFields) devices, including Optune Gio and Optune Lua, for the treatment of solid tumor cancers. Its pipeline consists of Trident, Lunar-2, Panova-3, Metis and other products and technologies for the treatment of Glioblastoma, Non-smell cell lung cancer and Pancreatic cancer. Geographically, the company derives majority of its revenue from the United States and rest from Germany, Japan and other markets.

About TDC Teradata Corporation

Teradata Corp focused on helping organizations improve business performance, enrich customer experiences, and integrate data across the enterprise. The company's platform provides companies with Harmonized Data: Trusted AI: Teradata VantageCloud: Teradata VantageCore: ClearScape Analytics: and Query Grid. The company generates majority of revenue from the United States.

Share on Social Networks: